JP2006515886A5 - - Google Patents

Download PDF

Info

Publication number
JP2006515886A5
JP2006515886A5 JP2006501021A JP2006501021A JP2006515886A5 JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5 JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
alkoxy
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006501021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006515886A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/001279 external-priority patent/WO2004064741A2/en
Publication of JP2006515886A publication Critical patent/JP2006515886A/ja
Publication of JP2006515886A5 publication Critical patent/JP2006515886A5/ja
Pending legal-status Critical Current

Links

JP2006501021A 2003-01-17 2004-01-20 化合物、組成物、および方法 Pending JP2006515886A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44087303P 2003-01-17 2003-01-17
US44391103P 2003-01-30 2003-01-30
PCT/US2004/001279 WO2004064741A2 (en) 2003-01-17 2004-01-20 Compounds, compositions, and methods

Publications (2)

Publication Number Publication Date
JP2006515886A JP2006515886A (ja) 2006-06-08
JP2006515886A5 true JP2006515886A5 (https=) 2006-10-19

Family

ID=32776034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006501021A Pending JP2006515886A (ja) 2003-01-17 2004-01-20 化合物、組成物、および方法

Country Status (4)

Country Link
US (1) US20070149500A1 (https=)
EP (1) EP1594849A4 (https=)
JP (1) JP2006515886A (https=)
WO (1) WO2004064741A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US6794379B2 (en) 2001-06-06 2004-09-21 Tularik Inc. CXCR3 antagonists
JP2005529076A (ja) 2002-02-15 2005-09-29 サイトキネティクス・インコーポレーテッド キナゾリノンの合成
RU2004135554A (ru) 2002-05-09 2006-01-20 Цитокинетикс, Инк. (Us) Пиримидиноны, композиции на их основе и способы их использования
EP1553931A4 (en) 2002-05-09 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1513820A4 (en) 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
CA2489367A1 (en) 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
EP1537089A4 (en) 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
WO2004034972A2 (en) 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
CN1809563A (zh) * 2003-06-20 2006-07-26 希龙公司 吡啶并[1,2－a]嘧啶－4－酮化合物用作抗癌药
WO2005041888A2 (en) * 2003-11-03 2005-05-12 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions and methods
EP1692112A4 (en) 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
RU2006138864A (ru) 2004-04-06 2008-05-20 Чирон Корпорейшн (Us) Ингибиторы митотического кинезина
WO2006008523A1 (en) * 2004-07-22 2006-01-26 Astrazeneca Ab Fused pyrimidones usefuel in the treatment and the prevention of cancer
EP1781674A1 (en) 2004-08-18 2007-05-09 AstraZeneca AB Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
EP1856128A4 (en) * 2005-01-19 2009-12-23 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
CA2593166A1 (en) * 2005-01-19 2006-07-27 Merck & Co., Inc. Mitotic kinesin inhibitors
JP2008546843A (ja) 2005-06-27 2008-12-25 アムゲン インコーポレイティッド 抗炎症性アリールニトリル化合物
US20070135435A1 (en) * 2005-11-02 2007-06-14 Xiangping Qian Certain chemical entities, compositions, and methods
WO2008086122A2 (en) 2007-01-05 2008-07-17 Novartis Ag Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
CN118027024A (zh) * 2022-11-14 2024-05-14 南京同诺康医药科技有限公司 吡啶并[1,2-a]嘧啶-4-酮衍生物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609598A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
JP2005511581A (ja) * 2001-11-07 2005-04-28 メルク　エンド　カムパニー　インコーポレーテッド 有糸分裂キネシン阻害剤
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1537089A4 (en) * 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
US20040024596A1 (en) * 2002-07-31 2004-02-05 Carney Laurel H. Noise reduction system
WO2004018058A2 (en) * 2002-08-21 2004-03-04 Cytokinetics, Inc. Compounds, compositions, and methods

Similar Documents

Publication Publication Date Title
JP2006515886A5 (https=)
JP2005523312A5 (https=)
RU2004133325A (ru) Соединения, композиции на их основе и способы их использования
CA2413426A1 (en) Methods and compositions utilizing quinazolinones
ES2705077T3 (es) Moduladores de receptores opioides
CN100491358C (zh) 嘧啶酮类化合物、组合物及方法
AU2009264431B2 (en) Pyrazolo-quinazolines
RU2009132605A (ru) Производные 5,6,7,8-тетрагидроптеридина в качестве ингибиторов hsp90
AU2004200573B2 (en) Method of Treating Nitrate-induced Tolerance
AU679608B2 (en) Imidazodiazepines
CA2747326C (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies
JP2014503534A5 (https=)
CA2866213A1 (en) Substituted azabicycles and use thereof
AU2003300255A1 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
CA2534990A1 (en) P-38 kinase inhibitors
CA2792725A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
EP1996550A2 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
KR20230010729A (ko) 단독 요법 및 병용 요법
MY139344A (en) 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
AU2009252220A1 (en) Inhibitor of analgesic tolerance
CN102665700A (zh) 治疗实体瘤和其它恶性肿瘤的方法和组合物
US20050220705A1 (en) Methods for treating non-melanoma cancers with PABA
EP2036909A1 (en) Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
CN101415426A (zh) c-Src抑制剂与嘧啶基氨基苯甲酰胺类化合物的组合治疗白血病的用途
JP2006502219A5 (https=)